NCT04857333

Brief Summary

The researchers are aimed to investigate the dynamic evolution of indeterminate pulmonary nodules by a long-term follow-up of patients with different characteristics. Influence factors of clinical decision-making that might contribute to overtreatment or delayed treatment will also be studied.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 23, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

3 years

First QC Date

April 19, 2021

Last Update Submit

March 15, 2023

Conditions

Keywords

Pulmonary noduleRadiologic pictureProspective observatory studyPsychological stateDecision-making

Outcome Measures

Primary Outcomes (2)

  • Time to surgical resection

    Time calculated from the date of identification of pulmonary nodule to the date of surgical resection

    The date of first documented diagnosis of pulmonary nodule by CT scan to the date of surgical resection, up to 60 months

  • Time to progression

    Time calculated from the date of identification of pulmonary nodule to the date of progression of pulmonary nodule based on evaluation of CT imaging

    The date of first documented diagnosis of pulmonary nodule by CT scan to the date of documented progression by CT scan, up to 60 months

Secondary Outcomes (3)

  • Proportion of malignancy

    The date of first documented diagnosis of pulmonary nodule by CT scan to the date of surgical resection, up to 60 months

  • Change of Hospital Anxiety and Depression Scale-Anxiety (HADS-A) score

    The date of enrollment in our cohort study when Hospital Anxiety and Depression Scale is measured to the date when primary endpoint( surgical resection) is reached, up to 60 months, with multiple measurements.

  • Change of Hospital Anxiety and Depression Scale-Depression (HADS-D) score

    The date of enrollment in our cohort study when Hospital Anxiety and Depression Scale is measured to the date when primary endpoint( surgical resection) is reached, up to 60 months, with multiple measurements.

Study Arms (1)

Pulmonary Nodule

Patients are recommended for using antibiotics, solely follow-up or surgical resection according to the current clinical guideline for management of indeterminate pulmonary nodule. No intervention is administered for this observatory study.

Diagnostic Test: CT scanDrug: AntibioticsProcedure: Surgical Resection

Interventions

CT scanDIAGNOSTIC_TEST

For patients with low-risk pulmonary nodules, follow-up CT scan is recommended

Pulmonary Nodule

For pulmonary nodules with features of infectious disease, antibiotics is recommended

Pulmonary Nodule

For persistent high-risk pulmonary nodules, surgical resection is recommended

Pulmonary Nodule

Eligibility Criteria

Age14 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants in this study are diagnosed with solitory or multiple indeterminate pulmonary nodules( ≤ 3cm ), and are willing to be followed-up for continous collection of their related disease information.

You may qualify if:

  • Patients with pulmonary nodules ≤ 3cm
  • Patients who provide electronic, written or oral consent to be enrolled in the follow-up cohort

You may not qualify if:

  • Patients with a surgical history of pulmonary nodules;
  • Patients who have obtained pathological diagnosis through surgery or non-surgical methods such as puncture;
  • Patients with pulmonary nodules that are likely metastatic from other sites;
  • Refuse to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, 510080, China

Location

Related Publications (2)

  • Wu J, Zhuang W, Chen R, Xu H, Li Z, Lan Z, Xia X, He Z, Li S, Deng C, Xu W, Shi Q, Tang Y, Qiao G. Impact of surgery versus follow-up on psychological distress in patients with indeterminate pulmonary nodules: A prospective observational study. Qual Life Res. 2025 Apr;34(4):1167-1177. doi: 10.1007/s11136-024-03876-w. Epub 2025 Jan 15.

  • Zhuang W, Tang Y, Xu W, Huang S, Deng C, Chen R, Zhang D, Zeng C, Tian D, Ben X, Lan Z, Wu H, Gao Z, Wang M, Chen Y, Shi Q, Qiao G. Should psychological distress be listed as a surgical indication for indeterminate pulmonary nodules: protocol for a prospective cohort study in real-world settings. J Thorac Dis. 2022 Mar;14(3):769-778. doi: 10.21037/jtd-21-1423.

MeSH Terms

Conditions

Solitary Pulmonary NoduleMultiple Pulmonary Nodules

Interventions

Tomography, X-Ray ComputedAnti-Bacterial Agents

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Image Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayTomographyAnti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Administrative Director, Department of Thoracic Surgery

Study Record Dates

First Submitted

April 19, 2021

First Posted

April 23, 2021

Study Start

January 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2025

Last Updated

March 16, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

All individual participant data are strictly protected for patient privacy according to the agreement in Informed Consent Form.

Locations